Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14201 - 14225 of 14679 in total
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Experimental
Experimental
Investigational
Iguratimod is under investigation in Rheumatoid Arthritis.
Investigational
Displaying drugs 14201 - 14225 of 14679 in total